S Lena Kang-Birken Dena El-Sayed John Prichard
10.1177/2325958218821653
J Int Assoc Provid AIDS Care
2019 Jan-Dec;18:2325958218821653.
hiv/aids calcium elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide mutation emergence resistance
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30798679/
Anti-HIV Agents / adverse effects Calcium / adverse effects Drug Interactions HIV Infections / virology Virus Activation
Anti-HIV Agents / adverse effects Calcium / adverse effects Drug Interactions HIV Infections / virology Virus Activation Case Reports Adult Calcium Carbonate / adverse effects Cobicistat / therapeutic use Drug Resistance, Viral Emtricitabine / therapeutic use Female HIV Infections / complications HIV Infections / drug therapy HIV-1 / drug effects HIV-1 / genetics Humans Leucovorin / adverse effects Quinolones / therapeutic use Tenofovir / therapeutic use Toxoplasmosis, Cerebral / complications Viral Load Anti-HIV Agents Quinolones elvitegravir Tenofovir Emtricitabine Calcium Carbonate Cobicistat Leucovorin Calcium
PMC6748456
30798679
HIV Viral Rebound Due to a Possible Drug-Drug Interaction between Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide and Calcium-Containing Products: Report of 2 Cases
2019